S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.49
+1.81
+10.85%
OM · Outset Medical, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$4.05
-0.16
(-3.69%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$4.05
$4.04
$4.26
52-WEEK RANGE
$4.05
$2.84
$15.94
What's happening
- OM is down 3.69% today, trading at $4.05. — Live quote
- Volume today (3,066) is well below its 3-month average of 194,020. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-0.80 actual vs. $-0.74 estimated (-7.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 5
Hold 2
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
OM
+13.75%
vs S&P 500
+0.97%
1-YEAR RETURN
OM
-72.83%
vs S&P 500
-87.39%
6-MONTH RETURN
OM
-4.09%
3-MONTH RETURN
OM
+2.43%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.80
Est. $-0.74
MISS -7.9%
2026-04-26 (Q1 2026)
$-0.83
Est. $-0.81
MISS -2.0%
2026-01-26 (Q4 2025)
$-0.84
Est. $-0.66
MISS -27.9%
2025-10-26 (Q3 2025)
$-0.69
Est. $-0.67
MISS -2.3%
Valuation Measures & Ratios
Enterprise Value4$143.4M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)0.68
Price / Book70.83
EV4 / Revenue1.22
EV4 / EBITDA—
Profit Margin-63.06%
Operating Margin-56.06%
Return on Equity (ROE8)-62.25%
Return on Assets (ROA9)-28.75%
Avg Volume (3M)194,020
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $80.3M | $70.2M | $251.9M | $342.3M | $78.0M |
| P/E | -1.09 | -0.87 | -2.80 | -3.21 | -0.61 |
| Price/Sales | 0.67 | 0.59 | 2.11 | 2.92 | 0.68 |
| Price/Book | 0.83 | 0.63 | 1.77 | 2.21 | 0.46 |
| EV/Revenue | 1.19 | 1.15 | 2.61 | 3.39 | 0.84 |
| EV/EBITDA | -2.32 | -2.21 | -4.57 | — | — |
| ROE | -76.13% | -72.65% | -63.29% | -68.95% | -75.42% |
| ROA | -30.26% | -32.53% | -32.50% | -36.95% | -42.54% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short792,696
Change from Prior Settlement-10.89%
% of Float—
Days to Cover (Short Ratio)5.93
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 0.7% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-05; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -63.1%. Finnhub fundamentals ↗
- Trailing 52-week price return is -72.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on OM
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $31.6M | $27.9M | $29.4M | $31.4M | $29.8M | $28.7M | $27.4M | $28.2M |
| Gross profit | $13.3M | $12.1M | $11.6M | $11.9M | $11.1M | $9.8M | $9.8M | $8.2M |
| Operating income | -$15.7M | -$16.9M | -$15.8M | -$16.9M | -$16.4M | -$23.8M | -$30.8M | -$36.9M |
| Net income | -$18.0M | -$19.0M | -$17.8M | -$18.5M | -$25.8M | -$27.9M | -$34.5M | -$39.9M |
| EPS (diluted) | $-0.97 | $-1.03 | $-1.00 | $-1.04 | $-3.66 | $-8.02 | $-9.96 | $-11.77 |
| EPS (basic) | $-0.97 | $-1.03 | $-1.00 | $-1.04 | $-3.66 | $-8.02 | $-9.96 | $-11.77 |
| Operating margin | -$50 | -$61 | -$54 | -$54 | -$55 | -$83 | -$112 | -$131 |
| Net margin | -$57 | -$68 | -$61 | -$59 | -$87 | -$97 | -$126 | -$142 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $242.4M | $249.5M | $264.5M | $277.3M | $288.8M | $301.2M | $275.8M | $292.9M |
| Total liabilities | $146.0M | $137.8M | $137.5M | $134.9M | $134.0M | $131.3M | $249.0M | $245.1M |
| Stockholders' equity | $96.3M | $111.7M | $127.0M | $142.4M | $154.8M | $169.9M | $26.8M | $47.8M |
| Total current assets | $227.8M | $236.7M | $250.9M | $265.4M | $275.6M | $286.6M | $258.2M | $275.3M |
| Total current liabilities | $43.9M | $37.6M | $37.6M | $37.4M | $36.9M | $34.2M | $45.4M | $42.4M |
| Cash & equivalents | $35.0M | $30.6M | $35.0M | $36.4M | $39.6M | $75.9M | $124.0M | $33.3M |
| Marketable securities (current) | $112.2M | $126.1M | $133.9M | $142.2M | $144.5M | $113.1M | $34.7M | $142.3M |
| Accounts receivable | $29.2M | $25.3M | $28.3M | $33.0M | $34.9M | $36.9M | $35.6M | $34.3M |
| Inventory | $47.3M | $49.6M | $47.6M | $49.3M | $52.2M | $55.8M | $59.4M | $61.4M |
| Property, plant & equipment | $3.7M | $4.1M | $4.7M | $5.3M | $6.2M | $6.9M | $8.1M | $9.5M |
| Other non-current assets | $411.0K | $353.0K | $317.0K | $538.0K | $560.0K | $818.0K | $2.2M | $484.0K |
| Accounts payable | $4.5M | $1.4M | $554.0K | $1.7M | $1.4M | $1.2M | $3.9M | $4.3M |
| Deferred revenue (current) | $14.0M | $12.6M | $13.8M | $14.9M | $14.0M | $13.2M | $12.8M | $12.8M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $6.0M | $5.1M | $4.1M | $3.6M | $3.2M | $2.7M | $3.1M | $2.8M |
| Long-term debt | $97.6M | $96.9M | $96.2M | $95.5M | $94.8M | $94.1M | $197.4M | $197.2M |
| Common stock & paid-in capital | $19.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $4.0K | $52.0K |
| Retained earnings | -$1.21B | -$1.19B | -$1.17B | -$1.15B | -$1.13B | -$1.12B | -$1.09B | -$1.06B |
| Accumulated other comprehensive income (loss) | -$136.0K | -$73.0K | $172.0K | $157.0K | $49.0K | $88.0K | $42.0K | $352.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$9.6M | -$12.8M | -$9.5M | -$6.3M | -$4.8M | -$25.7M | -$16.5M | -$20.6M |
| Investing cash flow | $14.2M | $7.9M | $8.6M | $3.0M | -$31.2M | -$78.1M | $108.2M | $15.9M |
| Financing cash flow | -$88.0K | $501.0K | $0 | $231.0K | -$384.0K | $55.7M | -$938.0K | $121.0K |
| Free cash flow | -$9.7M | -$12.9M | -$9.7M | -$6.5M | -$5.1M | -$25.8M | -$16.5M | -$21.0M |
| Capital expenditures | $111.0K | $65.0K | $223.0K | $160.0K | $292.0K | $123.0K | $43.0K | $395.0K |
| Depreciation & amortization | $627.0K | $795.0K | $881.0K | $1.0M | $1.2M | $1.3M | $1.4M | $1.4M |
| Share-based compensation | $2.7M | $3.5M | $4.1M | $5.1M | $3.5M | $3.0M | $4.9M | $6.4M |
| Change in accounts receivable | $5.0M | -$3.4M | -$1.8M | -$2.9M | -$574.0K | $1.5M | $1.9M | $139.0K |
| Change in inventory | -$2.3M | $2.2M | -$1.5M | -$3.0M | -$3.6M | -$3.7M | -$2.1M | -$225.0K |
| Change in accounts payable | $3.0M | $865.0K | -$1.1M | $338.0K | $270.0K | -$2.8M | -$441.0K | -$963.0K |
| Purchases of investments | $18.6M | $22.9M | $28.2M | $40.1M | $57.3M | $96.3M | $6.1M | $22.0M |
| Debt issued | $0 | $0 | $0 | $0 | $0 | $98.3M | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $119.5M | $113.7M | $130.4M | $115.4M | $102.6M |
| Gross profit | $46.8M | $38.6M | $29.0M | $17.8M | $7.6M |
| Operating income | -$66.7M | -$113.4M | -$169.8M | -$161.0M | -$130.5M |
| Net income | -$81.7M | -$128.0M | -$172.8M | -$163.0M | -$131.9M |
| EPS (diluted) | $-5.37 | $-36.96 | $-52.28 | $-3.38 | $-2.89 |
| EPS (basic) | $-5.37 | $-36.96 | $-52.28 | $-3.38 | $-2.89 |
| Operating margin | -$56 | -$100 | -$130 | -$140 | -$127 |
| Net margin | -$68 | -$113 | -$133 | -$141 | -$129 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $264.5M | $275.8M | $313.8M | $400.1M | $463.5M |
| Total liabilities | $137.5M | $249.0M | $190.9M | $154.1M | $89.4M |
| Stockholders' equity | $127.0M | $26.8M | $122.9M | $246.0M | $374.1M |
| Total current assets | $250.9M | $258.2M | $291.2M | $373.6M | $409.8M |
| Total current liabilities | $37.6M | $45.4M | $55.3M | $51.9M | $51.7M |
| Cash & equivalents | $35.0M | $124.0M | $68.5M | $73.2M | $182.3M |
| Marketable securities (current) | $133.9M | $34.7M | $134.8M | $214.3M | $157.1M |
| Accounts receivable | $28.3M | $35.6M | $33.0M | $28.1M | $25.6M |
| Inventory | $47.6M | $59.4M | $49.2M | $51.5M | $39.2M |
| Property, plant & equipment | $4.7M | $8.1M | $13.3M | $15.9M | $13.0M |
| Other non-current assets | $317.0K | $2.2M | $605.0K | $1.2M | $156.0K |
| Accounts payable | $554.0K | $3.9M | $5.8M | $603.0K | $1.8M |
| Deferred revenue (current) | $13.8M | $12.8M | $11.7M | $8.7M | $6.3M |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $4.1M | $3.1M | $5.8M | $7.1M | $4.0M |
| Long-term debt | $96.2M | $197.4M | $130.1M | $96.3M | $29.8M |
| Common stock & paid-in capital | $18.0K | $4.0K | $50.0K | $48.0K | $47.0K |
| Retained earnings | -$1.17B | -$1.09B | -$961.7M | -$789.0M | -$626.0M |
| Accumulated other comprehensive income (loss) | $172.0K | $42.0K | $68.0K | -$564.0K | -$184.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$46.3M | -$116.3M | -$131.4M | -$145.7M | -$130.3M |
| Investing cash flow | -$97.7M | $103.9M | $83.0M | -$66.3M | -$142.5M |
| Financing cash flow | $55.5M | $67.9M | $43.7M | $72.9M | $160.1M |
| Free cash flow | -$47.1M | -$117.2M | -$134.8M | -$154.1M | -$133.4M |
| Capital expenditures | $798.0K | $912.0K | $3.4M | $8.3M | $3.1M |
| Depreciation & amortization | $4.3M | $5.7M | $5.8M | $5.2M | $5.2M |
| Share-based compensation | $15.6M | $29.4M | $38.6M | $27.2M | $17.4M |
| Change in accounts receivable | -$3.8M | $5.0M | $5.1M | $2.5M | $19.1M |
| Change in inventory | -$11.8M | $10.9M | -$1.6M | $14.7M | $22.0M |
| Change in accounts payable | -$3.3M | -$1.9M | $5.3M | -$1.3M | -$3.1M |
| Purchases of investments | $222.0M | $156.6M | $172.3M | $261.2M | $178.4M |
| Debt issued | $98.3M | $66.5M | $33.2M | $96.1M | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding OM as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-01-20 to 2026-10-02
Recent transactions
- Insiders have net bought 208,960 shares over the last 182 days, across 2 purchases and 7 sales.
- Most recent: Leonard Braden Michael (Reporting person) — Open market purchase of 16,575 shares on 2026-10-02.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)244,909 sh(2 txns)
Sales (open market)35,949 sh(7 txns)
Net Shares+208,960
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Leonard Braden Michael | Reporting person | Open market purchase | 2026-10-02 | 16,575 |
| Trigg Leslie | Chair and CEO | Open market sale | 2026-08-17 | 3,437 |
| Brottem John L. | General Counsel | Open market sale | 2026-08-17 | 2,632 |
| Gaeta Renee | Chief Financial Officer | Open market sale | 2026-08-17 | 4,543 |
| HACKETT PATRICK T | Director | Grant / award | 2026-06-04 | 10,667 |
| OBOYLE KEVIN C | Director | Grant / award | 2026-06-04 | 10,667 |
| Prange Karen | Director | Grant / award | 2026-06-04 | 10,667 |
| LANG BRENT D. | Director | Grant / award | 2026-06-04 | 10,667 |
| GROSSMAN D KEITH | Director | Grant / award | 2026-06-04 | 10,667 |
| Drexler Karen | Director | Grant / award | 2026-06-04 | 10,667 |
| Nash Marc | EVP Operations R&D & Service | Open market sale | 2026-05-15 | 1,582 |
| Elliott Derick A. | EVP, Commercial | Grant / award | 2026-04-06 | 96,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-02 | Leonard Braden Michael | Reporting person | Open market purchase | 16,575 | $3.88 |
| 2026-10-01 | Leonard Braden Michael | Reporting person | Open market purchase | 228,334 | $3.53 |
| 2026-08-17 | Trigg Leslie | Chair and CEO | Open market sale | 3,437 | $4.39 |
| 2026-08-17 | Brottem John L. | General Counsel | Open market sale | 2,632 | $4.39 |
| 2026-08-17 | Gaeta Renee | Chief Financial Officer | Open market sale | 4,543 | $4.39 |
| 2026-06-26 | Brottem John L. | General Counsel | Grant / award | 59,830 | $0.00 |
| 2026-06-26 | Gaeta Renee | Chief Financial Officer | Grant / award | 71,630 | $0.00 |
| 2026-06-26 | Trigg Leslie | Chair and CEO | Grant / award | 99,160 | $0.00 |
| 2026-06-04 | HACKETT PATRICK T | Director | Grant / award | 10,667 | $0.00 |
| 2026-06-04 | OBOYLE KEVIN C | Director | Grant / award | 10,667 | $0.00 |
| 2026-06-04 | Prange Karen | Director | Grant / award | 10,667 | $0.00 |
| 2026-06-04 | LANG BRENT D. | Director | Grant / award | 10,667 | $0.00 |
| 2026-06-04 | GROSSMAN D KEITH | Director | Grant / award | 10,667 | $0.00 |
| 2026-06-04 | Drexler Karen | Director | Grant / award | 10,667 | $0.00 |
| 2026-06-03 | Gaeta Renee | Chief Financial Officer | Open market sale | 17,672 | $4.94 |
| 2026-05-15 | Trigg Leslie | Chair and CEO | Open market sale | 3,445 | $3.70 |
| 2026-05-15 | Nash Marc | EVP Operations R&D & Service | Open market sale | 1,582 | $3.70 |
| 2026-05-15 | Brottem John L. | General Counsel | Open market sale | 2,638 | $3.70 |
| 2026-05-15 | Leonard Braden Michael | Reporting person | In-the-money option exercise | 323,000 | $5.00 |
| 2026-05-11 | Leonard Braden Michael | Reporting person | In-the-money option exercise | 96,900 | $5.00 |
| 2026-05-08 | Leonard Braden Michael | Reporting person | In-the-money option exercise | 197,600 | $5.00 |
| 2026-04-06 | Elliott Derick A. | EVP, Commercial | Grant / award | 96,000 | $0.00 |
| 2026-02-17 | Brottem John L. | General Counsel | Open market sale | 2,842 | $3.35 |
| 2026-02-17 | Trigg Leslie | Chair and CEO | Open market sale | 3,361 | $3.35 |
| 2026-02-17 | Nash Marc | EVP Operations R&D & Service | Open market sale | 1,817 | $3.35 |
| 2026-01-21 | Nash Marc | EVP Operations R&D & Service | Open market sale | 980 | $4.98 |
| 2026-01-21 | Brottem John L. | General Counsel | Open market sale | 1,180 | $5.01 |
| 2026-01-20 | Nash Marc | EVP Operations R&D & Service | Open market sale | 5,375 | $5.12 |
| 2026-01-20 | Brottem John L. | General Counsel | Open market sale | 9,314 | $5.12 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:23 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-08-28 | 8-K | 2026-08-27 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-17 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-08-06 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-26 | View on SEC.gov → |
| 2026-06-17 | 8-K | 2026-06-14 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-04 | View on SEC.gov → |
Recent news
Headlines about OM (Outset Medical, Inc.). Links open the publisher — we don’t host full articles.
-
Husqvarna (OM:HUSQ B) Stock Sinks As Q3 Earnings Slip Into Loss
Simply Wall Street · 2026-10-22 -
Fabege (OM:FABG) Stock Faces Q3 Earnings Strength And P E Doubts
Simply Wall Street · 2026-10-22 -
Wihlborgs Fastigheter (OM:WIHL) Stock Faces Debt Pressure After Q3 Earnings
Simply Wall Street · 2026-10-22 -
Vertiseit (OM:VERT B) Stock Q3 Earnings Rebound Faces ARR Growth Gap
Yahoo Finance · 2026-10-22 -
Swedencare (OM:SECARE) Stock Price Meets Skepticism Despite Stronger Q3 Earnings
Simply Wall Street · 2026-10-22 -
Neobo Fastigheter (OM:NEOBO) Stock Price Faces Q3 Earnings Valuation Crunch
Simply Wall Street · 2026-10-22 -
AddLife (OM:ALIF B) Stock Can Q3 Results Justify Its Rich P/E?
Yahoo Finance · 2026-10-22 -
JM (OM:JM) Q3 Earnings Rebound Meets A Lingering Loss Profile
Yahoo Finance · 2026-10-22
No headlines in this category right now — try “All”.